Do Peptides Build Muscle?

For the compounds most often marketed for it, no — there is no controlled human evidence that they build muscle. Growth hormone is the most studied compound in this space by a wide margin, and the trials point in an unusually consistent direction: it produces measurable changes in body composition without demonstrated gains in strength or exercise capacity 13.

That pairing sounds like a contradiction, and it is the single most useful thing to understand about this whole topic. Once you know why a composition number can improve while nothing the person can do improves, most of the confident writing about peptides and muscle becomes much easier to read.

Why does growth hormone change body composition but not strength?

Because the standard measure of "lean mass" is not a measure of muscle. Body-composition scanning divides the body into fat, bone mineral and everything else, and that third compartment — reported as lean or fat-free mass — contains muscle, organs, connective tissue and a great deal of water. It is a bucket, not a muscle biopsy.

Growth hormone causes the body to retain sodium and fluid. Retained fluid goes into the lean compartment, so the lean-mass figure rises. Nothing about that rise tells you contractile tissue was added, and this is exactly the reading that gets converted into "it builds muscle" when the result is summarised for a general audience.

The pooled evidence in healthy older adults shows the pattern plainly. Across the controlled trials, growth hormone treatment was associated with an increase in lean body mass of roughly two kilograms and a decrease in fat mass of about the same, while strength and exercise capacity showed no improvement the studies could detect — alongside markedly higher rates of soft-tissue swelling, joint pain, carpal tunnel syndrome and disturbed glucose control 1.

A randomised controlled trial published in JAMA in 2002 tested growth hormone in healthy aged men and women over several months, alone and in combination with a sex steroid. Composition moved in the familiar direction. Function largely did not follow where growth hormone was given by itself, and the functional changes that did reach significance in men came from an arm in which a sex steroid had been added — a different intervention answering a different question — while adverse effects were common enough to be a finding in their own right 3.

So the honest summary of the most studied compound in the category is: the scan changes, the person does not. Anything downstream of that finding has to contend with it.

What about growth hormone releasing peptides?

They act one step further upstream, and there is no controlled human evidence that they build muscle either. Rather than supplying hormone from outside, growth hormone releasing peptides are described as prompting the pituitary to release more of the body's own — a pulsatile release, with the body's feedback loops still in place.

That difference is real pharmacologically and genuinely interesting. It is also, for this question, beside the point. If the mechanism works exactly as described, the downstream event is more circulating growth hormone — and what more circulating growth hormone does to strength in healthy adults is the question the previous section already answered 13. An upstream compound inherits the downstream evidence, and here the downstream evidence is not encouraging.

There is a second gap on top of that one. No controlled human trial has tested these compounds against placebo with strength or athletic performance as the endpoint. So the case for them rests on a mechanism argument stacked on a literature that did not demonstrate the outcome being claimed, which is a considerably weaker position than it usually sounds.

What about repair and recovery peptides?

Animal data, and no controlled human trials for those uses. The best-known repair compounds in this category have a rodent literature covering tendon, muscle and gut injury models, some of it striking. What none of them has is a randomised, placebo-controlled human trial testing whether people recover faster, train more, or end up stronger.

How much weight a promising animal result deserves has been measured rather than argued about. A systematic review in the BMJ compared animal experiments with the human trials of the same six interventions: the animal data agreed with the human result for three of them and disagreed for the other three 4. That is not a reason to dismiss animal work, which is the correct first step and stands behind almost every approved medicine. It is a reason to treat it as a filter rather than a preview.

The two compounds most often set against each other in this space are covered in a separate article on this site, which goes through what is actually different about them and where each one's evidence stops. The part relevant to this page is short: neither has controlled human evidence behind the claims made for muscle or recovery, and being compared with each other does not raise either of them.

Does anything peptide-based reliably change muscle in humans?

Yes — in one specific clinical situation. Where a diagnosed deficiency means the pituitary does not produce enough growth hormone, replacement therapy is established, evidence-based medicine, and improvements in body composition are part of why it is prescribed. That is a real effect in a real patient group, and it deserves to be stated clearly rather than skated past.

It also does not transfer. Restoring a hormone that is missing and adding more of one that is already present at normal levels are two different interventions, and they have been studied separately. The trials in healthy adults are the ones that tell you what the second does, and they are the trials that found composition moving without function following 3.

Deficiency is a diagnosis made on biochemical testing under specialist care, not a description of feeling stalled in the gym. "Growth hormone works in growth hormone deficiency" is true. "Growth hormone builds muscle" does not follow from it, and the trials designed to check whether it does came back the other way.

Why do people report results then?

For several ordinary reasons, none of which require anybody to be lying. Personal reports are real observations; they are just observations made without the machinery that lets you attribute a change to one cause. The common explanations:

• Other things changed at the same time. People rarely begin a new compound in the middle of an otherwise identical month — motivation, sleep, consistency and what they eat tend to shift together, and any of those can move the result on its own.
• Expectation. Blinded designs exist precisely because expectation reliably alters how people rate soreness, recovery, effort and their own appearance in the mirror.
• Fluid retention read as growth. Weight and limb measurements can rise from water alone, and that reads on a tape measure exactly like the thing everyone is hoping for.
• No control condition. Personal experience has a sample size of one and no parallel version of the same weeks without the compound to compare against, which is the one comparison that would answer the question.
• Timing. People often start something at a low point — after illness, a layoff or a bad stretch — and improvement from a low point happens anyway.
• Selective sharing. Experiences that went nowhere are less likely to be written up and posted than experiences that felt transformative, so what circulates is a filtered sample.

None of that is an accusation. Somebody can be entirely honest, observant and careful, and still be unable to separate a compound's effect from everything else happening in the same eight weeks. Separating those is not a matter of paying closer attention; it is the specific job a control group does, and it is the thing that is missing.

Are these compounds banned in sport?

Yes. Growth hormone, its releasing peptides, related growth factors and insulin are prohibited in competitive sport, and the rules are written by category rather than by naming every individual compound — so new sequences fall inside the prohibition automatically, without anyone having to update a list 2. A separate article on this site covers how those categories are drafted and why they are so difficult to test against.

The part that matters here is what a ban is not. Prohibition follows category, intent and detectability, not demonstrated efficacy — the rulebook is not a literature review. A compound can be banned in sport and still have no controlled evidence that it does anything for strength; the questions are settled by different institutions for different reasons 2. Reading a prohibition as a backhanded endorsement gets this exactly backwards.

What would settle the question?

A randomised, placebo-controlled trial in healthy adults with a functional endpoint — one that measures what participants can do rather than what a scanner reports about them. The difference between the two kinds of endpoint is doing an enormous amount of quiet work in this literature:

Composition endpoints are cheaper, quicker and more sensitive, so they get used, and a trial built on them can report changes that are entirely real as measurements while leaving the question of whether anybody got stronger completely open. That is a large part of why some of this literature reads more positively in summary than it does in full — the summaries quote the endpoint that moved 1.

The study that would settle it is not exotic: healthy adults, randomised to compound or placebo, blinded, training held constant across the groups, with strength and performance measured at the end and reported whichever way they fall. Until something of that shape is published and then reproduced by an independent group, the answer stays where it is.

So do peptides build muscle?

On the current evidence, for the compounds most often marketed for it: no demonstrated effect. The most studied compound in the whole category changes what a scan reports without changing what the person can lift, and the compounds positioned upstream of it inherit that result while adding no controlled human trials of their own 13.

That is not the same as saying nothing could ever be found. Untested is not disproven, and the absence of trials for many of these compounds says as much about who pays for clinical research as it does about the molecules. Something in this space may yet be shown to work; it simply has not been shown yet.

The thing worth carrying away is how much of the confident material on this topic rests on mechanism and composition numbers, and how little of it rests on anybody getting measurably stronger under conditions that could tell. When a claim about muscle is made, the useful question is which of those two it is standing on — and the answer is usually available in a couple of minutes.